H.U. Group Holdings×BML
Different ways of making money, on the same scale.
Same yardstick
| Metric | H.U. Group HoldingsFY ending Mar 2026 | BMLFY ending Mar 2026 |
|---|---|---|
| Revenue | ¥247.4B | ¥150.3B |
| COGS ratio | 71.1% | 67.6% |
| Operating margin | 1.9% | 6.9% |
| Net margin | 2.8% | 5.2% |
| FCF margin | 6.8% | 7.0% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- H.U. Group HoldingsPrimary industry: CRO & Clinical Testing
- BMLPrimary industry: CRO & Clinical Testing
CompanyRank
Revenue growth
- H.U. Group Holdings37.512 peers
- BML29.212 peers
- H.U. Group Holdings
Profitability
- H.U. Group Holdings19.213 peers
- BML73.113 peers
- H.U. Group Holdings
Cash conversion
- H.U. Group Holdings95.511 peers
- BML68.211 peers
- H.U. Group Holdings
Efficiency
- H.U. Group Holdings88.513 peers
- BML65.413 peers
- H.U. Group Holdings
Financial strength
- H.U. Group HoldingsN/A
- BMLN/A
- H.U. Group Holdings
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
H.U. Group Holdings¥247.4B · keeps ¥2 per ¥100
BML¥150.3B · keeps ¥7 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.